In this episode of ETF Battles, you’ll watch an audience requested biotech clash between the iShares Biotechnology ETF (IBB) vs. the SPDR S&P Biotech ETF (XBI). Which biotech stock fund is the better choice?
Ron DeLegge @ETFguide referees this biotech duel with guest judges Jessica Ferringer from ETF.com and Eric Balchunas at Bloomberg sharing their research insights.
Each ETF is judged against the other in key categories like cost, exposure strategy, performance, yield and a mystery category. Find out who wins the battle!
ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. If you’re ready for a bold trade, visit http://www.Direxion.com
Get in touch with our judges:
–YOUR RESOURCES FROM RON–
Free ETF Guides https://tinyurl.com/4uvfx4m7
Get help with your investing habits https://tinyurl.com/2xrpbzz8
Enroll in online classes built for investors https://tinyurl.com/ewn3mh9v
Get feedback on your portfolio’s risk https://tinyurl.com/cz4ahj52
Check your investment performance https://tinyurl.com/cz4ahj52
60 Smart Ways to Retire Better https://60-smart-ways.etfguide.com/
–LISTEN TO ETF BATTLES–
3) Amazon Music
4) Google Podcasts